Specialty: Retina, Surgery Vitreoretinal Diseases Medical School: Wayne State University School of Medicine Residency: Detroit Medical Center, Kresge Eye Institute Fellowship: Kresge Eye Institute Appointment Location: Detroit, Taylor, Board Certification: American Board of Ophthalmology Special Activities: Member, American Academy of Ophthalmology
Specialty: Ophthalmic Plastic & Reconstructive Surgery Medical School: Wright State University School of Medicine Residency: University of Texas Southwestern, Dallas, Texas Fellowship: Kresge Eye Institute Appointment Location: Detroit Board Certification: American Board of Ophthalmology Clinical Interests: surgical procedures of the eyelids and eyebrows, cosmetic surgery of the eyelid and periocular region, orbit and lacrimal system surgery, thyroid eye disease and orbital inflammation Research Interests: relationships between eyelid and eyebrow position, practice management, orbital pathology, thyroid eye disease Special Activities: Member, American Academy of Ophthalmology, Member, American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS), Member, Michigan Society of Eye Physicians and Surgeons Publications: Beaulieu R, McDonnell E, Scofield-Kaplan SM, Evers BM, Hogan RN, Mancini R. Conjunctival changes following Muller’s muscle conjunctival resection. International Ophthalmology. 2022;42(6):1689-1695. Kally PM, Cheng OT, Do TH, Beaulieu RA. Periocular non-tuberculous mycobacterial infection after autologous fat transfer with micro-needling and fractional radiofrequency skin resurfacing. Orbit. Published online June 24, 2022:1-3. Tukel M, Beaulieu R, Kahana A. Resolution of persistent traumatic supraorbital pain after neuroma excision. Orbit. 2022;41(2):253-255 Gutermuth, B., Beaulieu, R. (2022); Late-Onset Orbital Infection Following Blowout Fracture Repair with a Medpor Titan Implant: A Case Report. Invest. Ophthalmol. Vis. Sci. 2022;63(7):602 – A0303 Keen JA, Beaulieu RA, Black EH. Central Core Myopathy: A Case Report of a Rare Etiology of Myogenic Blepharoptosis. J Neuroophthalmol. 2021 Dec 16. Epub ahead of print. Chen, P., Beaulieu, R., Black E. Aberrant regeneration of cranial nerve three following schwannoma resection. Ophthalmic Plastic and Reconstructive Surgery. 2021 Sep-Oct 01;37(5):e191 Winker KP, Beaulieu R, Bevill L, Mishulin A, Black EH. (2020) Effects of aspirin on postoperative bruising and bleeding complications in upper eyelid surgery. Ophthalmic Plastic and Reconstructive Surgery. 36(6), 575-578. Beaulieu R., Mancini R. (2018) Reply re: “Frontalis muscle contraction and the role of visual deprivation and eyelid proprioception”. Ophthalmic Plastic and Reconstructive Surgery. 34(5), 498. Beaulieu R., Andre K., Mancini R. (2018) Frontalis muscle contraction and the role of visual deprivation and lid proprioception. Ophthalmic Plastic and Reconstructive Surgery. 34(6), 552-556. Moore, N., Beaulieu, R., Parikh, P., McCarthy, M., Warwar, R. (2017). Prevalence of ocular injuries in the setting of trauma: a 6-year retrospective analysis from a level-one trauma center. Invest. Ophthalmol. Vis. Sci.; 58(8):5959. Beaulieu RA, Tamboli DA, Armstrong BK, Hogan RN, Mancini R. (2016) Reversible Charles Bonnet Syndrome After Oculoplastic Procedures. Journal of Neuroophthalmology 38(3), 334-336. Beaulieu, R., McCarthy, M., Markert, R., Parikh, P., Ekeh, A. (2014). Predictive factors and models for trauma patient disposition. Journal of Surgical Research, 190(1), 264–269. Beaulieu, R., Parikh, P., Ekeh, A., Markert, R., Parikh, P., McCarthy, M. (2013). Early prediction of trauma patient discharge disposition. ASC 2014 Abstract Archive.58.13, pg. 790. Beaulieu, R., Warwar, R., Buerk, B. Canthaxanthin Retinopathy with visual loss: A case report and review. Case Reports in Ophthalmological Medicine, 2013, 1–4. López-Mondéjar, R, Beaulieu, R, Ros, M, Pascual, JA (2012). SCAR-based real-time TaqMan PCR for early detection of Fusarium oxysporum in melon seedlings under greenhouse nursery conditions. Crop Protection, 33, 1–6. Beaulieu, R., López-Mondéjar, R., Tittarelli, F., Ros, M., Pascual, J. A. (2011). qRT-PCR quantification of the biological control agent Trichoderma harzianum in peat and compost-based growing media. Bioresource Technology, 102(3), 2793–2798. Venu, R., Beaulieu, R., Graham, T., Medina, A., Boehm, M. (2009). Dollar spot fungus Sclerotinia homoeocarpa produces oxalic acid. International Turfgrass Society Research Journal, 11 part 1. 263-270. Beaulieu, R., Martínez Medina, A., Boehm, M. (2008). Oxalic acid production by Sclerotinia homoeocarpa: The causal agent of dollar spot. Phytopathology 98:S20. Updated and listed as faculty on website
Specialty: Retina, Vitreoretinal Surgery Medical School: Albany Medical College, Albany, NY Residency: North Shore – Long Island Jewish Health System, Great Neck, NY Fellowship: St. Michael’s Hospital, University of Toronto, Toronto, ON Appointment Locations: Detroit Board Certification: American Board of Ophthalmology & Ophthalmology, Fellow of the Royal College of Surgeons of Canada Dr Yoganathan is an Associate Professor at the Kresge Eye Institute, Department of Ophthalmology Visual, and Anatomical Sciences at Wayne State University. She is also an Assistant Professor in the Department of Ophthalmology and Vision Sciences at the University of Toronto, Adjunct Professor at the Schulich School of Medicine and Dentistry at Western University, and Adjunct Professor in Biomedical Sciences at the University of Windsor. Dr. Yoganathan has been working cross-border for 13 years, currently practicing at the Kresge Eye Institute and Windsor Regional Hospital. With regards to her education, Dr. Yoganathan, born and raised in Montreal, completed a Bachelor of Science in Physiology at McGill University and obtained her medical degree at Albany Medical College in upstate New York. She then graduated from residency at North Shore – Long Island Jewish in New York. She completed her VitreoRetinal fellowship at the University of Toronto. While in practice, Dr Yoganathan also graduated from the Royal College of Physicians Educator’s Certificate for physician leaders and obtained a Masters of Science in Health Research Methodology at McMaster University. Deepa Yoganathan is the inaugural Director of the Professional Development Initiative and Quality Improvement Residency Program at the Kresge Eye Institute. She has also dedicated great effort to documenting the history of the field of retina as the History of Retina Chair, Written Vignettes for the American Society of Retina Specialists (ASRS). She is an examiner for the Royal College of Physicians and Surgeons of Canada Ophthalmology Board Exam, on the Board of Directors for Fighting Blindness Canada, and Past President of the Toronto Ophthalmological Society. She is the chair for several conferences including the Canadian Ophthalmic Imaging Symposium. Dr Yoganathan is an Honor Award member of the ASRS and was also awarded the designation of Fellow of the ASRS. She also is an invited member of IntRIS (International Retinal Imaging Society). In April 2020, she initiated a weekly webinar called RETINA CONNECT, bringing retina panelists together to discuss the history of retina, medical and surgical practice patterns, and advances in the field of retina including artificial intelligence. She thoroughly enjoys teaching her residents and fellows and was awarded Teacher of the Year in her first year of practice. Her interests include retinal trauma, diabetic retinopathy, patient advocacy and navigation, and practice efficiency and clinic design. Dr Yoganathan lives in Northville, Michigan with her husband, 6 year old son, and 5 year old daughter. Honors: 2011 – Teacher of the Year, Ophthalmology Residency Program, University at Buffalo 2010 – June Callwood Oustanding Achievement Award, Voluntarism in Ontario for St Michael’s cataract mission 2003 – Family Physician’s Regional Representation Award, Albany Medical College 2002 – Alumni Association Scholarship, Albany Medical College 2001 – Commitment to Montreal Community Scholarship, Luxme International 1998 – Montreal Children’s Hospital Research Institute Scholarship for research in Endocrine Genetics, McGill University 1998 – Rona and Irving Levitt Scholarship for research proposal in Oncology, McGill University 1998 – Caritas Internationalis – Outstanding Volunteer Award for mission to Croatia and dedication to Croatian Community in Montreal Publications: 1. Lin, H, Lema G, Yoganathan, P. Prognostic indicators of visual acuity after open globe injury and retinal detachment repair. Retina 2016;36(4):750-757. 2. Lam WC, Albiani DA, Yoganathan P et al. for the CHROME Study Group. Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study. Clinical Ophthalmology, 2015; 9:1255-68. 3.Ding J, Sieminski S, Yoganathan, P. Resolution of ocular siderosis glaucoma following removal of 30 year old intraocular foreign body. Can J Ophthalmol 2015;50(5):82-85. 4. Bregu M, Tesha PE, Wong DT, Giavedoni LR, Altomare F, Yoganathan P, Chow DR, Romano MR. Nausea and fluorescein injection speed. Ophthalmology 2012; 119(6):1281-1281. 5. Tesha PE, Giavedoni LR, Berger AR, Altomare F, Chow DR, Navajas EV, Yoganathan P, Wong DT, Principe A. Subconjunctival lidocaine before laser treatment: a randomized trial. Ophthalmology 2010;117(9):1810-4. 6. Yoganathan P, Berger AR. Topical Ketorolac in Vitreoretinal Surgery. Evidence Based Ophthalmology 2009;10(2):105-106. 7. Becker HM, Yoganathan P, Berger AR. Endophthalmitis post complicated cataract surgery associated with Klebsiella pneumoniae. Ann Ophthalmol 2009;41(34):189- 190. 8. Herschorn AB, Yoganathan P, Margolin EA, Berger AR. Inadvertent subretinal triamcinolone injection in a case of recurrent scleritis. Can J Ophthalmol 2009;44(4):33-34. 9. Yoganathan P, Conti S, Kavalec C. The use of intraoperative fluoroscopy as an aid for the removal of radiopaque intraorbital foreign bodies. Ophthalmic Surg Lasers Imaging 2008;39(5)436:4. 10. Ronan SM, Yoganathan P, Chien FY et al. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Retina 2007;27(5):535-540. 11. Yoganathan P, Deramo VA, Lai JC, Fastenberg DM. Visual improvement following intravitreal bevacizumab (Avastin) in exudative age-related macular degeneration. Retina 2006;26(9):994-998. 12. Bakri SJ, Nickel J, Yoganathan P, Beer PM. Photodynamic therapy for choroidal neovascularization associated with submacular hemorrhage in age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2006;37:278-283. 13. 2004 Yoganathan P, Meyer DR, Farber MG. Bilateral lacrimal gland involvement with Kimura disease in an African American male. Arch Ophthalmol 2004;122:917-919.
Assistant Professor, Department of Ophthalmology
Wayne State University School of Medicine
Kresge Eye Institute
Specialty: Uveitis, Vitreoretinal Surgery
Medical School: University of Texas Southwestern Medical Center
Residency: University of Texas Southwestern Medical Center
Fellowship: Retina, Kresge Eye Institute, Wayne State University
Appointment Locations: Detroit
Board Certification: American Board of Ophthalmology
Clinical Interests: Retinal Detachment, Diabetic Retinopathy, Macular Degeneration, Retinal Vascular Diseases, Inflammatory Retinal Diseases, Inherited Retinal Diseases, Retinopathy of Prematurity
Honors: Alpha Omega Alpha Medical Honor Society
Hobbies: Table Tennis, Clarinet, Fishing, Cooking
1. Lin X , Patel SB, Zhang A, Brill D, Le K, He YG. Fluorescein Angiography of Persistent Incomplete Vascularization of the Retina after Bevacizumab Therapy in Retinopathy of Prematurity. Journal of VitreoRetinal Diseases. 2019 April. 2. Padidam S, Burke M, Apple D, Hu J, Lin X . Possible Ledipasvir-sofosbuvir Associated Uveitis. JAMA Ophthalmology. 2019 Mar 28. PMID 30920588. 3. Malbin B, Padidam S, Burke M, Akhter M, Eby A, Mishulin A, Lin X . Intravenous Prostaglandin E1 Infusion for Acute Central Retinal Artery Occlusion. Ophthalmic Surgery Lasers Imaging Retina. 2019 (accepted for publication). 4. Malbin B, Patel HP, He Y, Le K, Lin X . Comparative Eye Effect of Unilateral Intravitreal Bevacizumab, Ranibizumab, and Aflibercept for Diabetic Macular Edema. Journal of VitreoRetinal Diseases. Feb 1, 2019. 5. Padidam S, Le K, Lin X. Refractive Trend of Stage 3 Retinopathy of Prematurity. J Pediatric Ophthalmol Strabismus. 2018 Nov 19;55(6):403-406. PMID: 30452767 6. Patel SB, Reddy N, Lin X, Whitson JT. Optical Coherence Tomography Retinal Nerve Fiber Layer Analysis in Eyes with Long Axial Lengths. Clinical Ophthalmology. 2018 May 3; 12:827-832. PMID 29765196 7. Mishulin A, Ghandi S, Apple D, Lin X, , Hu J, Abrams GW. Inducible Transient Central Retinal Artery Vasospasm: A Case Report. Retina Cases Brief Reports. 2017 Sep 27. PMID 28957956 8. Lin X., Apple D., Hu J., Tewari A. Advancements of vitreoretinal surgical machines. Current opinion in ophthalmology 28, no. 3 (2017): 242-245. PMID 28257298
Department of Ophthalmology and Anatomy/Cell Biology
Wayne State University School of Medicine
Kresge Eye Institute
Specialty: Cataract, Dry Eye Disease, Comprehensive Ophthalmology
Medical School: Albert Einstein College of Medicine, Yeshiva University
Residency: Ophthalmology, Henry Ford Hospital, Detroit, Michigan
Fellowship: National Institutes of Health, Bethesda, MD
Appointment Locations: Bingham Farms and Detroit
Board Certification: American Board of Ophthalmology
Clinical Interests: Cataract surgery, dry eye diease, diabetic eye exams, macular degeneration, inflammatory eye diseases, glaucoma, external eye diseases
Research Interests: Developing thymosin beta 4 as a novel therapy for corneal wound healing, inflammation, and dry eye disease
Special Activities: Member, American Academy of Ophthalmology; Member, Association for Research in Vision and OphthalmologyHonors:
2011 AFER/Pfizer Ophthalmics Carl Camras Translational Research Award, ARVO, May 1, 2011, Fort Lauderdale, FL.
2012 Voted to Top Doctors Metro Detroit
2012 Top Ophthalmologist, International Association of Ophthalmologists
2013 Voted to Best Doctors of America
2014 Voted to Best Doctors of America
Sosne G, Ousler GW. Thymosin β4 Ophthalmic Solution for Dry Eye: A Randomized, Placebo-Controlled Phase 2 Clinical Trial Conducted Using the Controlled Adverse Environment (CAE™) Model. Expert Opinion. In revision.
Sosne G, Kim C, Kleinman HK. Thymosin β4 Significantly Reduces the Signs of Dry Eye in a Murine Controlled Adverse Environment Model of Experimental Dry Eye. Expert Opinion. In press.
Sosne G, Dunn SP, Kim C. Thymosin beta 4 Significantly Improve Signs and Symptoms of Severe Dry Eye in a Phase 2 Clinical Trial. CORNEA In press.
Sosne G, Qiu P, Ousler GW 3rd, Dunn SP, Crockford D. Thymosin β4: a potential novel dry eye therapy. Ann N Y Acad Sci. 2012 Oct;1270:45-50. doi: 10.1111/j.1749-6632.2012.06682.x.
Goldstein, AL, Hannappel E, Sosne G, Kleinman HK. Thymosin β4: A Multi-Functional Regenerative Peptide Basic Properties and Clinical Applications. Expert Opin Biol Ther. 2012 Jan;12(1):37-51. Epub 2011 Nov 10.
Qiu P, Wheater MK, Qiu Y, Sosne G. Thymosin beta 4 inhibits TNF-alpha-induced NF-kappaB activation, IL-8 expression, and the sensitizing effects by its partners PINCH-1 and ILK. FASEB J. 2011 Feb 22, [Epub ahead of print]
Dunn SP, Heidemann DG, Chow CYC, Crockford D, Turjman N, Angel J, Allan CB, and Sosne G. “Treatment of Chronic Non-Healing Neurotrophic Corneal Epithelial Defects with Thymosin 4”
Ann N Y Acad Sci. 2010 Apr;1194:199-206. Dunn, SP, Heidemann DG, Chow CY, Crockford D, Turjman N,Angel, J, Allan CB, Sosne G. Arch Ophthalmol. Treatment of Chronic Nonhealing
Neurotrophic Corneal Epithelial Defects With Thymosin Beta 4. 2010 May; 128(5):636-8. Sosne G, Qiu P, Goldstein AL, Wheater MK. Biological activities of thymosin beta 4 defined by active sites in short peptide sequences. FASEB J. 2010 Jul;24(7):2144-51. Epub 2010 Feb 23. Sosne G, Qiu P, Christopherson PL, Wheater MK. Thymosin beta 4 suppression of corneal
NFkappaB: A potential anti-inflammatory pathway. Exp Eye Res. 2007 Apr;84(4):663-9. Gabriel Sosne, M.D.
The David Barsky, M.D. Endowed Chair
Professor and Chairman, Department of Ophthalmology Wayne State University School of Medicine
Director, Kresge Eye Institute
Medical School: Wayne State University School of Medicine
Residency: Ophthalmology, Kresge Eye Institute, Wayne State University School of Medicine, Detroit, Michigan
Fellowship: Glaucoma, Wilmer Eye Institute, Johns Hopkins University
Appointment Locations: Detroit, Southfield, Taylor and Troy
Board Certification: American Board of Ophthalmology
Clinical Interests: Glaucoma and cataracts
Research Interests: Surgical and pharmaceutical clinical trials, socioeconomics of ophthalmology, educational research
Special Activities: Associate Dean, GME, Wayne State University; Vice President, Academic Affairs, Detroit Medical Center; Member, Ophthalmology Residency Review Committee, ACGME
Honors: ACGME Parker J. Palmer “Courage to Teach” award, Best Doctors in America